Richard Labelle

Richard Labelle is currently the Chief Operating Officer (COO) at Medexus Pharmaceuticals, Inc., a position he assumed in June 2024.14 He has been with the company since February 2014, initially serving as General Manager of Canadian Operations before his promotion to COO.1

Prior to his current role, Labelle held various positions within the company, including:

1. General Manager of Canadian Operations at Medexus1
2. Vice President of Sales and Marketing at Pediapharm (now known as Medexus Pharmaceuticals)3

Labelle has over 30 years of experience in the pharmaceutical industry.1 Before joining Medexus, he led the creation of Sanofi's consumer healthcare division in Canada as General Manager and managed business development teams and various business units in different therapeutic areas.1

In terms of education, Richard Labelle holds a Bachelor of Commerce from the University of Quebec and an MBA from the McGill – HEC executive program.1

Throughout his career at Medexus, Labelle has been involved in significant company developments, such as the commercial launch of OtixalTM in Canada in 20183 and the conclusion of Metoject litigation in 2024.2